Publication | Closed Access

A novel LSD1 inhibitor NCD38 ameliorates MDS-related leukemia with complex karyotype by attenuating leukemia programs via activating super-enhancers

Hematological MalignancyMedicineMixed-phenotype Acute LeukemiaMds-related LeukemiaMyeloid NeoplasiaLeukemia ProgramsAnti-cancer AgentPharmacologyCell BiologyNovel TherapyTumor BiologyDrug DiscoveryComplex Karyotype